Orthopedic Bone Cement Market (2024 - 2030)

Orthopedic Bone Cement Market Summary

For instance, according to the International Osteoporosis Foundation, it is estimated that 200 million women are affected by osteoporosis. The prevalence varies with age, affecting about 66% of women aged 90, 40% of women aged 80, 20% of women aged 70, and 10% of women aged 60.

Moreover, the increasing number of sport-related injuries such as hip, knee, and shoulder fractures and a rising number of orthopedic surgeries drive the market growth. For instance, according to the National Safety Council in the U.S., 3.7 million people were affected by some sport-related injuries in 2023. These injuries are as follows,

The market is expected to experience further growth due to an increasing number of road accidents. For instance, according to NHTSA’s National Center for Statistics and Analysis report published by the U.S. Department of Transportation, around 2.38 million individuals were injured in 2022 due to motor vehicle crashes, and 2.50 million in 2021. Thus, such a rise in road accidents increases the chances of multiple bone fractures, boosting the market growth.

Physicians are the actual customers of medical devices who decide on the material to be used during surgery. The growing number of physicians is expected to increase the customer pool for orthopedic bone cement manufacturers, leading to overall market growth. An increasing number of orthopedic surgeries are expected to drive demand for the bone cement market. For instance, according to data published by Regenexx in July 2021, 7 million orthopedic surgeries are performed in the U.S. annually. Bone cement is now widely used in joint and fracture repair surgeries instead of traditional devices such as screws and wire. The increasing use of bone cement by physicians is anticipated to boost market growth over the forecast period.

Market Concentration & Characteristics

The market for orthopedic bone cement is characterized by a high degree of innovation due to advancements in materials science and surgical techniques. For example, the University of Bath, in collaboration with Summit Medical, is conducting research on the development of bone cement delivery and mixing systems for use in total joint replacement surgery.

The market is characterized by a medium level of merger and acquisition (M&A) activity. These M&As facilitate distribution channels and enable companies to accelerate product development.

Regulations play an important role in shaping the market and ensuring the safety, efficacy, and quality of the product. The FDA has issued an order to reclassify polymethylmethacrylate (PMMA) bone cement from class III (requiring premarket approval) to class II (subject to special controls). This document was developed to facilitate this reclassification. Once reclassified, this device is designed to secure metallic or polymer prosthetic implants to the living bone for knee, hip, and other joint arthroplasty procedures.

Several market players are expanding their business by launching new products to expand their product portfolio. Rising product launches create more opportunities for market players. For instance, in August 2024, Heraeus Medical, a provider of bone cement, introduced COPAL G+V dual antibiotic-loaded bone cement for infection management.

Material Insights

The polymethyl methacrylate (PMMA) segment dominated the market with a revenue share of 73.1% in 2023 and is anticipated to witness the fastest CAGR over the forecast period owing to rising research activities and investments. For instance, in January 2022, SetBone Medical Ltd., manufacturer of bone cement, which is used for orthopedic procedures and treatment of spinal vertebrae fractures, raised a funding of USD 1.6 million to develop and offer superior solutions to patients suffering from vertebral compression fractures. Moreover, PMMA is used in the surgical fixation of artificial joints. Its primary function is to transfer forces from bone to prosthesis.

The calcium phosphate segment is anticipated to witness significant growth over the forecast period. The increasing incidence of fractures among the aging population and the rise in product launches are expected to boost market growth. For instance, in July 2022, curasan AG, a Germany-based company and provider of bone cement, expanded its portfolio with the launch of CERASORB CPC Bone Void Fillers (Calcium Phosphate Cement) for trauma, orthopedic, and maxillofacial surgery. It is a biocompatible, osteoconductive, synthetic, and bioresorbable mineral bone cement composed of phosphate salts and calcium finely dispersed in a biocompatible oil phase.

Product Insights

The antibiotic-loaded bone cement (ALBC) segment dominated the market with a revenue share of 56.4% in 2023 and is expected to witness the fastest CAGR over the forecast period. ALBC enables high concentrations of antibiotics at the surgical site by reducing systemic side effects and increasing the antibiotic concentration at the operative site. Currently, the U.S. FDA has approved gentamicin, vancomycin, clindamycin, and tobramycin antibiotic-loaded bone cement. For example, Heraeus Medical GmbH, a manufacturer of bone cement, offers COPAL G+C, a high-viscosity bone cement with Clindamycin and Gentamicin.

The bone cement without antibiotics segment is anticipated to witness significant growth over the forecast period. For example, Tecres S.p.A. offers Cemex Isoplastic, a high-viscosity bone cement without antibiotics, which is especially used for cementing the knee and the acetabulum. Similarly, Heraeus Medical GmbH, a manufacturer of bone cement, offers PALACOS R, a high-viscosity bone cement without antibiotics, which is specially used for attaching partial or total joint endoprostheses in bone.

End-use Insights

The hospitals segment dominated the market in 2023 with a revenue share of 50.1%. The large patient pool catered to hospitals, their dominance in emerging and low-income countries, and the rise in the number of orthopedic surgeons and hospitals providing orthopedic surgeries are anticipated to fuel the segment's growth. As of August 2023, there are 1148 hospitals in the UK, including 218 private and 930 NHS hospitals. Moreover, 2,654 orthopedic and trauma surgeons are currently working in the NHS in the UK.

The outpatient facilities segment is anticipated to register the fastest CAGR over the forecast period. Outpatient facilities provide a convenient and easily accessible option for patients requiring minor orthopedic procedures without needing prolonged hospital stays. As the trend towards ambulatory care continues to grow, outpatient facilities are becoming increasingly popular for patients seeking quicker recovery times and reduced healthcare costs associated with inpatient hospital stays.

Regional Insights

The North America orthopedic bone cement market dominated globally in 2023 and accounted for the largest global revenue share of 51.1%. This large share is attributed to increased musculoskeletal disorders, such as rheumatoid arthritis and osteoarthritis. In addition, the presence of reimbursement policies and the well-established healthcare infrastructure further stimulate market growth. Moreover, the growing emphasis on minimally invasive surgeries and the increasing geriatric population in the region are anticipated to drive market growth.

U.S. Orthopedic Bone Cement Market Trends

The U.S. orthopedic bone cement market in the held the largest share in 2023, owing to the local presence of several key players with an established distribution channel. Favorable reimbursement policies for orthopedic surgical procedures in the U.S. are another factor responsible for the market's dominance. In April 2023, Abyrx Inc. received additional approvals from the Food and Drug Administration (FDA) for MONTAGE Settable, Resorbable Bone Putty for cranial bone cement and bone void filler.

Europe Orthopedic Bone Cement Market Trends

Europe orthopedic bone cement market is anticipated to register a considerable CAGR during the forecast period. The growing patient pool due to medical tourism and a strong distribution network of manufacturers is expected to drive growth in Europe. Favorable healthcare policies can also be attributed to the growing demand over the forecast period.

Germany orthopedic bone cement market is anticipated to register a considerable growth rate during the forecast period. The increasing number of road accidents in the country contributes to the increased demand for orthopedic bone cement. For instance, according to Statistisches Bundesamt (Destatis), around 21,600 people were injured in road traffic accidents in Germany in 2023.

The UK orthopedic bone cement market is anticipated to register the fastest CAGR during the forecast period. The UK's National Health Service (NHS) offers universal healthcare coverage, ensuring access to orthopedic procedures for all residents, which stimulates market growth. In addition, the growing prevalence of orthopedic conditions boosts market growth. For instance, according to the National Institute for Health and Care Excellence, around 3.6 women and 1.5 men develop rheumatoid arthritis per 10,000 people per year in the UK.

Asia Pacific Orthopedic Bone Cement Market Trends

The orthopedic bone cement market in the Asia Pacific region is anticipated to register the fastest CAGR during the forecast period, owing to the rising prevalence of orthopedic conditions such as osteoarthritis and rheumatoid arthritis due to lifestyle changes and an aging population. This region is anticipated to exhibit enormous growth due to growing medical tourism, increasing per capita income, increasing healthcare spending by the government, and raising awareness.In May 2022, Granulab, a subsidiary of KPower, launched Malaysia’s Halal-certified synthetic bone cement PrsteomaxTM, which is calcium phosphate-based.

The Japan orthopedic bone cement market is anticipated to register the fastest CAGR during the forecast period. Technologically advanced healthcare systems, with a strong focus on innovation and the launch of new products, are propelling market growth. In addition, with an aging population, there is a growing need for orthopedic treatments to address age-related conditions, boosting market growth.

Key Orthopedic Bone Cement Company Insights

Key participants in the market are focusing on devising innovative business growth strategies in the form of partnerships & collaborations, product portfolio expansions, geographical expansions, and mergers & acquisitions.

Recent Developments

• In January 2024, Enovis acquired LimaCorporate S.p.A., an orthopedic company. This strategic move enhances Enovis' standing in the global orthopedic reconstruction market by integrating Lima's proven surgical solutions and technologies into its portfolio.

Orthopedic Bone Cement Market